← Leaderboards
William S Brimijoin
Mayo Clinic Coll Of Medicine, Rochester
$9,491,336
Attributed
$11,291,373
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2007–20$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$11,291,373 · 5
By mechanism
DP1$3,936,008 · 1
UG3$2,826,121 · 1
R01$2,324,343 · 1
UH3$2,204,901 · 1
P50$0 · 1
Top collaborators
- Kah-Whye Peng3 shared
Most similar at Mayo Clinic Coll Of Medicine, Rochester
Same institution · by research overlap
- Phillip A Low$10,116,600
- Paola Sandroni$614,937
- Michael L Camilleri$18,731,842
- Steven A Vernino$5,812,716
- Eduardo Benarroch$757,740
Others in their field
Top investigators on “Hydrolase”
- John Damon Chodera · Sloan-Kettering Inst Can Research$39,488,414
- David Heimbrook · Leidos Biomedical Research, Inc.$26,054,235
- Chang-Guo Zhan · University Of Kentucky$25,313,992
- Benjamin F Cravatt · Scripps Research Institute$20,061,534
- Nabil J. Alkayed · Johns Hopkins University$18,393,099
- Bruce D Hammock$17,640,422
Research focus
HydrolaseGene TherapyRewardsCocainePharmaceutical PreparationsEnzymesSafetyButyrylcholinesterasePlasmaCocaine AbuseRodentGene TransferDrug Seeking BehaviorGene Transfer VectorPreventToxic EffectAddictionProteinsDoseSelf-AdministeredHydrolase GeneAdenovirus VectorGenerationsRattus
Grant awards (19)
Definitive Preclinical Studies of Hydrolase Gene Transfer to Treat Cocaine Abuse$853,821
UH3 · FY2020 · DA
Definitive Preclinical Studies of Hydrolase Gene Transfer to Treat Cocaine Abuse$1,351,080
UH3 · FY2019 · DA
Definitive Preclinical Studies of Hydrolase Gene Transfer to Treat Cocaine Abuse$1,395,173
UG3 · FY2017 · DA · contact PI
Definitive Preclinical Studies of Hydrolase Gene Transfer to Treat Cocaine Abuse$1,430,948
UG3 · FY2016 · DA · contact PI
Cocaine hydrolase gene therapy for cocaine abuse (DPI)$764,845
DP1 · FY2014 · DA · contact PI
Cocaine hydrolase gene therapy for cocaine abuse (DPI)$118,722
DP1 · FY2014 · DA · contact PI
Cocaine hydrolase gene therapy for cocaine abuse (DPI)$734,251
DP1 · FY2013 · DA · contact PI
Cocaine hydrolase gene therapy for cocaine abuse (DPI)$764,845
DP1 · FY2012 · DA · contact PI
Cocaine hydrolase gene therapy for cocaine abuse (DPI)$764,845
DP1 · FY2011 · DA · contact PI
Development of a Human Hydrolase to Treat Cocaine Abuse and Overdose: Rat Models$311,549
R01 · FY2011 · DA · contact PI
Cocaine hydrolase gene therapy for cocaine abuse (DPI)$788,500
DP1 · FY2010 · DA · contact PI
Development of a Human Hydrolase to Treat Cocaine Abuse and Overdose: Rat Models$321,191
R01 · FY2010 · DA · contact PI
Development of a Human Hydrolase to Treat Cocaine Abuse and Overdose:Rat Models$732,603
R01 · FY2009 · DA · contact PI
Development of a Human Hydrolase to Treat Cocaine Abuse and Overdose: Rat Models$324,441
R01 · FY2009 · DA · contact PI
Development of a Human Hydrolase to Treat Cocaine Abuse and Overdose: Rat Models$313,577
R01 · FY2008 · DA · contact PI
Development of a Human Hydrolase to Treat Cocaine Abuse and Overdose: Rat Models$320,982
R01 · FY2007 · DA · contact PI
ANIMAL MODELS OF AUTONOMIC FAILURE$0
P50 · FY2002 · NS
ANIMAL MODELS OF AUTONOMIC FAILURE$0
P50 · FY2001 · NS
ANIMAL MODELS OF AUTONOMIC FAILURE$0
P50 · FY2000 · NS